WorldPing
WorldPingSTAT
Opinion: The new geography of abortion care
Even before Dobbs, patients had “begun reorganizing abortion care outside traditional health care settings,” writes Jennifer Karlin.
Brief by WorldPing · Original reporting by STAT
STAT
Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs
WorldPingMedicare’s new weight loss drug program “risks creating barriers at precisely the moment when confidence in broader GLP‑1 coverage is most needed,” writes Jeffrey Millstein.
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STATRelated news
WorldPing
WorldPingPhys.org
Color-sensing yeast could make biofactories more programmable and precise
Baker's yeast is one of biotechnology's most important microorganisms. It has long been used to leaven bread and ferment beer.
Brief by WorldPing · Original reporting by Phys.org
WorldPingThe Guardian
Oil prices hover near $90 a barrel and gold hits two-month high as Trump makes new demands on Iran – business live
US president demands compensation for damage incurred by US, complicating standoff with Tehran Oil prices have see-sawed: Brent crude jumped more than 2% to just over $90 a barrel, the highest level since 31 July, but has now dipped 0.3% to $87.53 a barrel.
Brief by WorldPing · Original reporting by The Guardian
Hacker News
More than 10 firms pay up to $100k a month for access to Truth Social posts
Article URL: https://www.bbc.com/news/articles/ce3q5nxpgk1o Comments URL: https://news.ycombinator.com/item?id=49255672 Points: 131 # Comments: 106…
Brief by WorldPing · Original reporting by Hacker News
WorldPingGizmodo
OpenAI’s Only Ethicist Reportedly Left Last Month. She Wasn’t Replaced
OpenAI’s Only Ethicist Reportedly Left Last Month. She Wasn’t Replaced — full report at Gizmodo.
Brief by WorldPing · Original reporting by Gizmodo
CNBC World
Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.
Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.
Brief by WorldPing · Original reporting by CNBC World